Benha University
Staff Search:
Go
Login
You are in:
Home
/
Publications
Prof.
Mohamed
Abd
Elaziz
Metwally
Ali
::
Publications:
Research Fields
hepatitis
patients
chronic HCV
hepatic fibrosis
prediction
liver
serum
Number of publications is 34
Title
1-
A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV
2-
High body mass index is associated with advanced hepatic fibrosis in patients chronic hepatitis C. Journal of Hepatology 2002; 36, Suppl 1, 240. (Presented in the Eurobean Association of Study of Liver Diseases and Intenational Association of Study of Liver Disease annual meeting, 2001, Madrid, Spain). Primary author
3-
Role of serum leptin in patients with liver cirrhosis and hepatocellular carcinoma complicating chronic viral hepatitis.
4-
Previous and silent hepatitis B infection in patients with chronic hepatitis C: Risk factors for severe hepatic fibrosis.
5-
A scoring model for prediction of relapse among chronic HCV genotype 4 patients treated with peginterferon and ribavirin.
6-
Pulmonary functions after injection sclerotherapy of esophageal varices and after band ligation.
7-
Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin
Abstract
8-
High insulin resistance is associated with low rapid virological response in chronic HCV patients.
9-
CSF lactate: A rapid accurate diagnostic test for acute bacterial meningitis.
Abstract
10-
Serum ferritin level as a predictor of response to pegylated interferon/ribavirin therapy in Egyptian chronic hepatitis C patients.
11-
Prediction of relapse among chronic HCV genotype 4 patients treated with PEG-IFN and Ribavirine.
12-
Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.
Abstract
'
|
Full paper
13-
Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.
Abstract
'
|
Full paper
14-
A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.
Abstract
'
|
Full paper
15-
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C.
Abstract
'
|
Full paper
16-
. Predictors and non invasive identification of severe liver fibrosis in patients with chronic hepatitis C
Abstract
'
|
Full paper
17-
Prevalence and risk factors of hepatitis C among pregnant females in Egypt. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt) Liver International Vol 26 (Suppl 1) September 2006. Primary Author.
18-
Neurophysiologic and psychometric changes in patients with liver cirrhosis.
19-
Serum level of tumor necrosis factor-alpha in patients with hepatic encephalopathy due to chronic liver diseases.
20-
Histopathological characterization of genotype 4 chronic hepatitis C.
21-
Elevation of pancreatic enzymes in patients with chronic liver diseases. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt)
22-
Reliability and validity of urine screening leukocyte esterase strips in diagnosis of spontaneous bacterial peritonitis.
23-
Clinical Significance of Hepatic Iron Deposition and Serum Iron Values in Patients with Chronic Hepatitis C Infection
Full paper
24-
Regression of Fibrosis and Cirrhosis in Chronic HCV Patients Treated with Interferon Based Therapy
25-
Comparison of the VERSANT HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy
Abstract
'
|
Full paper
26-
Hepatitis C virus infection as a risk factor for development of type 2 diabetes mellitus: A prospective cross-sectional study.
27-
Tumor necrosis alpha promoter gene polymorphisms and diabetes in patients with chronic hepatitis C: Evidence in favor of an association.
28-
Does Normal ALT Exclude Severe Hepatic Fibrosis in Patients with Chronic Hepatitis C? Gastroenterology 2002; Suppl A 631. (Oral presentation in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA) Primary author
29-
Does High Body Mass Index Affect Hepatic Fibrosis, Steatosis, and Inflammation in Patients with Chronic Hepatitis C? Gastroenterology 2002; 123, 1 Suppl: Pg. 52 A M1632. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author
30-
A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV. Gastroenterology 2002; 123, 1 Suppl: pg. 50 A M1621. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author
31-
Comparison of Detection of Hepatitis C Virus (HCV) by Transcription-Mediated Amplification (TMA) versus COBAS AMPLICOR™ HCV Test, version 2.0 (AMPLICOR) in Patients Undergoing Antiviral Therapy. (Presented in the American Association of Study of Liver Diseases annual meeting, 2002, Boston, Massachusetts, USA). Co-author.
32-
A population based epidemiological study of Helicobacter Pylori in Egypt.
33-
Independent predictors of severe liver fibrosis in chronic hepatitis C.
34-
Significance of Hepatic Iron Deposition and Serum Iron Indices in Liver Fibrosis Associated with Chronic Hepatitis C.